Venture Life has announced a new license agreement and three new international distribution agreements. The license relates to a new mouth ulcer product developed by the group's Biokosmes division, highlighting the company's innovation and development capabilities. International distribution agreements have been signed for Gelclair and Pomi-T, demonstrating the group's global reach and its ability to maximise the value of acquired brands. We believe these new agreements epitomise Venture Life's ....
09 Jan 2023
Cenkos: Venture Life Group Plc -- Commercial development
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Cenkos: Venture Life Group Plc -- Commercial development
Venture Life Group Plc (VLG:LON) | 58.5 -0.3 (-0.8%) | Mkt Cap: 74.8m
- Published:
09 Jan 2023 -
Author:
Chris Donnellan -
Pages:
7 -
Venture Life has announced a new license agreement and three new international distribution agreements. The license relates to a new mouth ulcer product developed by the group's Biokosmes division, highlighting the company's innovation and development capabilities. International distribution agreements have been signed for Gelclair and Pomi-T, demonstrating the group's global reach and its ability to maximise the value of acquired brands. We believe these new agreements epitomise Venture Life's ....